Sleep Disorders Trial, Recruiting NCT07498491 Sponsor: National University of Natural Medicine Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT07498491
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older (male or non-pregnant female)
  • People who have been experiencing pain for at least 3 months
  • People who rate their average pain over the past week as 3 or higher on a scale of 0 to 10
  • People who are physically able to lift a weighted blanket that equals 10% of their body weight (between 10 and 25 lbs.) without help
  • People who are willing to sleep with a weighted blanket (10–25 lbs.) every night for 35 days total (including a 7-day adjustment period)
  • People who are willing to keep their eating habits, physical activity, and body weight stable throughout the study
  • People who are willing to complete online questionnaires and surveys and attend virtual appointments
  • People who are able to give informed consent and follow the study procedures
  • People who can speak, read, and understand English
  • People who have access to WiFi for virtual visits and online surveys

Who may not be able to join:

  • People under 18 years of age
  • People who are currently using a weighted blanket (though a washout period may be available — confirm with trial site)
  • People who are unable to lift a 10–25 lb. weighted blanket without assistance
  • People who are unwilling or unable to sleep with the weighted blanket every night
  • People who have certain breathing or respiratory conditions, including obstructive sleep apnea, COPD (including emphysema or chronic bronchitis), tuberculosis, or severe asthma
  • People who have lung cancer
  • People who have certain heart conditions, including congestive heart failure or severe cardiomyopathy
  • People who have severe peripheral artery disease or severe or uncontrolled type 2 diabetes
  • People who have recently had surgery or have an open wound
  • People who are pregnant, breastfeeding, or planning to become pregnant within the next 35 days
  • People who share a bed with an infant or young child
  • People with a known allergy or sensitivity to any part of the study materials, including cotton fabric or natural and plant-based dyes
  • People who experience claustrophobia
  • People who are currently taking part in another pain research study
  • People whose participation is considered unsuitable by the study investigator for safety reasons or because it could affect the reliability of the results — including people whose pain level increases during the baseline or active phases of the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Carina Staab, DC, MEd, National University of Natural Medicine

Phone: 503-552-1862

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National University of Natural Medicine
Registry
ClinicalTrials.gov
Start date
27 May 2026
Est. completion
31 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in self-reported pain intensity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov